Comparison of two screws for maxillary expansion in prepubertal children

ISRCTN ISRCTN18263886
DOI https://doi.org/10.1186/ISRCTN18263886
Secondary identifying numbers LF1
Submission date
04/10/2016
Registration date
08/11/2016
Last edited
04/01/2024
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Oral Health
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Background and study aims
The dental arches are the two arches of teeth, one on each jaw (upper and lower arch). A posterior crossbite is a misalignment of the teeth that occurs when the upper arch and/or the upper jaw are narrower than the lower arch, and can happen on one (unilateral) or both (bilateral) sides of the mouth. Treatment of a posterior crossbite usually involves expanding the upper arch with either a fixed or removable orthodontic appliance (brace). Expansion with fixed expanders may be more successful than removable expansion plates at correcting posterior crossbites in children. Growing patients may report undesirable side effects during the expansion phase with fixed expanders, such as pain and mouth ulcers. Pain could be reduced by modifying the amount of force applied during the expansion. It is not known whether an expansion screw that uses moderate and continuous force could cause less pain compared with a standard screw that uses heavy and intermittent force. The aim of this study is to compare the effectiveness and side effects of a screw for maxillary expansion that uses moderate and continuous force with a standard expansion screw that uses heavy and intermittent force.

Who can participate?
Children aged between 6 and 14 with a posterior crossbite

What does the study involve?
Participants are randomly allocated to be treated with one of two types of rapid maxillary expanders, either with an expansion screw that uses moderate and continuous force or a standard expansion screw that uses heavy and intermittent force. Participants are followed-up every 2 weeks during the active phase of expansion (about 3 months) and then they are checked every month until the completion of the study (1 year after the start of treatment).

What are the possible benefits and risks of participating?
Participants may benefit from correction of their posterior crossbite. The possible risks include pain and mouth ulcers.

Where is the study run from?
1. University of Florence (Italy)
2. University of Rome Tor Vergata (Italy)

When is the study starting and how long is it expected to run for?
January 2016 to September 2018

Who is funding the study?
Investigator initiated and funded

Who is the main contact?
Dr Lorenzo Franchi
lorenzo.franchi@unifi.it

Contact information

Dr Lorenzo Franchi
Public

Via del Ponte di Mezzo 46-48
Florence
50127
Italy

ORCiD logoORCID ID 0000-0002-2072-460X
Phone +39 (0)55 7945602
Email lorenzo.franchi@unifi.it

Study information

Study designThree-centered superior parallel two-group randomized clinical trial with balanced randomization and blind examiner
Primary study designInterventional
Secondary study designRandomised parallel trial
Study setting(s)Hospital
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details to request a patient information sheet
Scientific titleComparison of two screws for maxillary expansion in prepubertal children: a multicenter randomized controlled trial
Study objectivesThe objective of this randomized controlled trial (RCT) is to compare the efficacy and side effects of a screw for maxillary expansion that uses moderate and continuous forces (test) and a standard expansion screw that uses heavy and intermittent forces (control).
Ethics approval(s)Pediatric Ethics Committee of the Meyer Paediatric Hospital, 29/04/2016, ref: 57/2016
Health condition(s) or problem(s) studiedMaxillary arch constriction
InterventionPatients will be randomized to receive a screw for maxillary expansion that uses moderate and continuous forces (Memoria Leaf Spring Activated Expander A2704, Leone SpA) (test) or a standard expansion screw that uses heavy and intermittent forces (Rapid Expander with Telescopic Guides A2620, Leone SpA) (control).

Randomisation: Computer-generated, balanced, with allocation concealment by opaque sequentially numbered sealed envelopes.

The test expander will be activated by the operators every 2 weeks. The control expander will be activated (1/4 of a turn) by the parents of the patients every day. Patients will be followed-up every 2 weeks during the active phase of expansion (about 3 months) and then they will be checked every month until the completion of the study (1 year after the start of treatment).
Intervention typeProcedure/Surgery
Primary outcome measure1. Maxillary intermolar width, measured at baseline and at one-year follow-up
2. Pain, measured using a visual analogue scale (VAS) for the first 12 weeks (a total of 12 questionnaires)
Secondary outcome measures1. Difficulties in speaking, measured using VAS every week for the first 12 weeks (a total of 12 questionnaires)
2. Difficulties in keeping the expander clean, measured using VAS every week for the first 12 weeks (a total of 12 questionnaires)
3. Treatment satisfaction of both the patients and the patients' parents, evaluated at one-year follow up
4. Complications, recorded during the 1-year follow up period
5. Variables either on dental casts or postero-anterior cephalograms, measured at baseline and at one-year follow up
Overall study start date06/01/2016
Completion date30/11/2019

Eligibility

Participant type(s)Patient
Age groupChild
Lower age limit6 Years
Upper age limit14 Years
SexBoth
Target number of participants56 (28 per centre)
Total final enrolment56
Key inclusion criteria1. Children in prepubertal stage (age between 6 and 14 years)
2. Negative posterior transverse discrepancy of at least 3 mm eligible for maxillary expansion
2. The first molars should be erupted with a mixed dentition stage in early transitional period or inter-transitional period
Key exclusion criteria1. Age older than 14 years or younger than 6 years
2. Deciduous dentition or mixed dentition in the late transitional period or permanent dentition
3. Maturation stage of cervical vertebrae CS3 or greater
4. Agenesis of maxillary second premolars
5. Periodontal disease
6. Neurologic or systemic disease
7. Allergy to nickel
8. Cleft lip and/or palate
9. Patients irradiated in the neck-head area
10. Chemo- or immune-therapy in the previous 5 years
Date of first enrolment05/09/2016
Date of final enrolment22/11/2018

Locations

Countries of recruitment

  • Italy

Study participating centres

University of Florence
Department of Surgery and Translational Medicine
50127
Italy
University of Rome Tor Vergata
Department of Clinical Sciences and Medicine
00133
Italy

Sponsor information

Leone Orthodontics and Implantology
Industry

Via P. a Quaracchi, 50
Sesto Fiorentino (Firenze)
50019
Italy

Funders

Funder type

Other

Investigator initiated and funded

No information available

Results and Publications

Intention to publish date01/08/2020
Individual participant data (IPD) Intention to shareYes
IPD sharing plan summaryAvailable on request
Publication and dissemination planTo be confirmed at a later date
IPD sharing planThe datasets generated during and/or analysed during the current study will be available upon request from Dr Lorenzo Franchi (lorenzo.franchi@unifi.it)

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 20/11/2020 23/11/2020 Yes No
Results article 11/06/2021 14/06/2021 Yes No
Results article 03/01/2024 04/01/2024 Yes No

Editorial Notes

04/01/2024: Publication reference added.
14/06/2021: Publication reference added.
23/11/2020: Publication reference and total final enrolment number added.
05/09/2019: The following changes have been made to the trial record:
1. The overall trial end date has been changed from 05/09/2018 to 30/11/2019.
2. The recruitment end date has been changed from 31/10/2019 to 22/11/2018.
3. The intention to publish date has been changed from 30/06/2020 to 01/08/2020.
18/10/2018: The following changes have been made to the trial record:
1. The target number of participants has been changed from "72" to "56 (28 per centre)"
2. The total target enrolment has been changed from "72" to "56"
3. The recruitment end date has been changed from 05/09/2018 to 31/10/2019
4. The University of Trieste has been removed as a trial participating centre and has been removed from the plain English summary
5. The intention to publish date has been changed from 05/09/2019 to 30/06/2020